Evidence map›Paper›PMID 39345812›Full record

ArticleACS central science2024

Reactive Noble-Gas Compounds Explored by 3D Electron Diffraction: XeF

Klemen Motaln, Kshitij Gurung, Petr Brázda, Anton Kokalj, Kristian Radan, Mirela Dragomir, Boris Žemva, Lukáš Palatinus, Matic Lozinšek

Abstract read
In one paragraph

Article in ACS central science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Coordination of XeFInorganic chemistry · 2026
    Article
  2. Article
  3. Article
  4. Protonated decafluorobenzophenone and the decafluorobenzophenone-arsenic pentafluoride adduct.Acta crystallographica. Section C, Structural chemistry · 2025
    Article
  5. Crystal Structures of XeFInorganic chemistry · 2025
    Article
  6. Article
  7. Article
  8. Single-crystal structure of the spicy capsaicin.Acta crystallographica. Section C, Structural chemistry · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Klemen MotalnJožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.
Kshitij GurungDepartment of Structure Analysis, Institute of Physics of the Czech Academy of Sciences, Na Slovance 1999/2, Prague 8, 18221, Czech Republic.
Petr BrázdaDepartment of Structure Analysis, Institute of Physics of the Czech Academy of Sciences, Na Slovance 1999/2, Prague 8, 18221, Czech Republic.
Anton KokaljJožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-7237-0041
Kristian RadanJožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.
Mirela DragomirJožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-4910-253X
Boris ŽemvaJožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.
Lukáš PalatinusDepartment of Structure Analysis, Institute of Physics of the Czech Academy of Sciences, Na Slovance 1999/2, Prague 8, 18221, Czech Republic.ORCID https://orcid.org/0000-0002-8987-8164
Matic LozinšekJožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-1864-4248

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in 3D electron diffraction (3D ED) have succeeded in matching the capabilities of single-crystal X-ray diffraction (SCXRD), while requiring only submicron crystals for successful structural investigations. One of the many diverse areas to benefit from the 3D ED structural analysis is main-group chemistry, where compounds are often poorly crystalline or single-crystal growth is challenging. A facile method for loading and transferring highly air-sensitive and strongly oxidizing samples at low temperatures to a transmission electron microscope (TEM) for 3D ED analysis was successfully developed and tested on xenon(II) compounds from the XeF

Identifiers

PMID39345812
PMCPMC11428288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.